Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.290
-0.220 (-4.88%)
At close: Apr 2, 2026, 4:00 PM EDT
4.400
+0.110 (2.56%)
After-hours: Apr 2, 2026, 4:10 PM EDT
Bolt Biotherapeutics Employees
Bolt Biotherapeutics had 23 employees as of December 31, 2025. The number of employees decreased by 29 or -55.77% compared to the previous year.
Employees
23
Change
-29
Growth
-55.77%
Revenue / Employee
$334,565
Profits / Employee
-$1,451,130
Market Cap
8.24M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 23 | -29 | -55.77% |
| Sep 30, 2025 | 40 | -12 | -23.08% |
| Dec 31, 2024 | 52 | -48 | -48.00% |
| Dec 31, 2023 | 100 | 6 | 6.38% |
| Dec 31, 2022 | 94 | 3 | 3.30% |
| Dec 31, 2021 | 91 | 26 | 40.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| CollPlant Biotechnologies | 57 |
| CalciMedica | 16 |
| Kiora Pharmaceuticals | 12 |
| BioRestorative Therapies | 11 |
| Aprea Therapeutics | 8 |
| TransCode Therapeutics | 7 |
| Creative Medical Technology Holdings | 4 |
BOLT News
- 22 days ago - Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Bolt Biotherapeutics to Participate in Upcoming March Conferences - GlobeNewsWire
- 5 months ago - Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027 - GlobeNewsWire
- 8 months ago - Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 11 months ago - Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 11 months ago - Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates - GlobeNewsWire
- 1 year ago - Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025 - GlobeNewsWire